Analysts are moving in opposite directions across key sectors this week. The divergence is sharpest in healthcare and consumer stocks.
DexCom grabbed the most bullish attention. The consensus target price rose to $85.21, up from $84.67. The glucose monitoring firm carries a $29bn market cap. Short interest sits at just 4.4% of free float — bears are thin on the ground.
General Mills saw the opposite move. Analysts trimmed the average target to $37.00 from $37.56. The cereal giant faces sustained pressure on volumes. Short interest is 9.3% of free float, one of the higher readings among large-cap consumer staples names.
Darden Restaurants won a positive target revision. The Olive Garden parent's consensus target ticked up to $226.23. Restaurant stocks have bounced on easing food cost inflation. Darden's short interest is moderate at 5.1% of free float.
Lennar drew a bearish target cut. Analysts pulled the homebuilder's consensus target to $89.50 from $90.14. Rate sensitivity still weighs on the sector. Lennar carries 8.8% short interest as a percentage of free float — shorts are not giving up on housing.
Biogen also saw a target dip to $220.13. The biotech's consensus sits at 14 Holds and 21 Sells — a deeply cautious read.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
